LUMITIN - Trademark Details
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Serial Number
79149533
Registration Number
4741346
Word Mark
LUMITIN
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2021-12-10
Filing Date
2014-03-28
Registration Number
4741346
Registration Date
2015-05-26
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2015-03-10
Attorney Name
Law Office Assigned Location Code
L80
Employee Name
POLZER, NATALIE M
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the words "LUMITIN".
Goods and Services
Medicines for humans used for the treatment of choroidal neovascularization induced by high myopia, macular edema induced by retinal vein occlusion, diabetic macular edema, wet age-related macular degeneration accompanied by very low vision acuity, the inhibition of neovascularization, back-of-the-eye neovascularization, aged-relatedmacular degeneration, retinal vein occlusion, neoplastic disease and cancer, angiogenesis disease; Pharmaceutical preparations for the treatment of diabetes, cardiovascular disease and disorder, neoplastic disease and disorder, cancer, disease and disorder of immune system, angiogenesis disease and disorder, ophthalmic diseases and disorder, mental disease and disorder, aged-related macular degeneration; Injectable preparations for medical use, namely, for the treatment of oculopathy, choroidal neovascularization induced by high myopia, macular edema induced by retinal vein occlusion, diabetic macular edema, wet age-related macular degeneration accompanied by very low vision acuity, the inhibition of neovascularization, back-of-the-eye neovascularization, aged-related macular degeneration, retinal vein occlusion, neoplastic disease, angiogenesis disease and cancer; Aqueous formula, namely, water-based pharmaceutical preparations for the treatment of cardiovascular disease and disorder, neoplastic disease and disorder, disease and disorder of immune system, ophthalmic diseases and disorder, inflammation; Biochemical drugs and preparations for medical use, namely, for the prevention, treatment and alleviation of angiogenesis disease, oculopathy, neoplastic disease, cancer, all of the foregoing being available by prescription only
Translation of Words in Mark
The wording "LUMITIN" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-12-10
Primary Code
005
Correspondences
Name
Alex Patel
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1209786
International Registration Date
2014-03-28
International Publication Date
2014-07-24
International Renewal Date
2024-03-28
Auto Protection Date
2016-01-24
International Status
001 - Request for extension of protection established
International Status Date
2014-07-24
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event Date | Event Description |
2014-07-24 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2014-07-29 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2014-07-29 | ASSIGNED TO EXAMINER |
2014-07-31 | NON-FINAL ACTION WRITTEN |
2014-08-01 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2014-08-01 | REFUSAL PROCESSED BY MPU |
2014-08-01 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2014-08-02 | APPLICATION FILING RECEIPT MAILED |
2014-08-22 | REFUSAL PROCESSED BY IB |
2015-01-06 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2015-01-08 | ASSIGNED TO LIE |
2015-01-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2015-01-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2015-01-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2015-01-31 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2015-02-18 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2015-03-10 | PUBLISHED FOR OPPOSITION |
2015-03-10 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2015-05-26 | REGISTERED-PRINCIPAL REGISTER |
2015-08-26 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2015-09-23 | FINAL DISPOSITION PROCESSED |
2015-09-23 | FINAL DISPOSITION NOTICE SENT TO IB |
2015-10-09 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2020-05-26 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
2021-06-05 | NEW REPRESENTATIVE AT IB RECEIVED |
2021-12-10 | CANCELLED SECTION 71 |